Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 17
2003 18
2004 30
2005 32
2006 21
2007 12
2008 13
2009 4
2010 10
2011 7
2012 8
2013 16
2014 7
2015 8
2016 4
2017 4
2018 3
2019 10
2020 14
2021 18
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

244 results
Results by year
Filters applied: . Clear all
Page 1
Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
Huang KM, Zavorka Thomas M, Magdy T, Eisenmann ED, Uddin ME, DiGiacomo DF, Pan A, Keiser M, Otter M, Xia SH, Li Y, Jin Y, Fu Q, Gibson AA, Bonilla IM, Carnes CA, Corps KN, Coppola V, Smith SA, Addison D, Nies AT, Bundschuh R, Chen T, Lustberg MB, Wang J, Oswald S, Campbell MJ, Yan PS, Baker SD, Hu S, Burridge PW, Sparreboom A. Huang KM, et al. Among authors: sparreboom a. Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2020168118. doi: 10.1073/pnas.2020168118. Proc Natl Acad Sci U S A. 2021. PMID: 33495337 Free PMC article.
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.
Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, Hecht DP, Klute KA, Morrison VA, Pini TM, Rosner GL, Runowicz CD, Shayne M, Sparreboom A, Turner S, Zarwan C, Lyman GH. Griggs JJ, et al. Among authors: sparreboom a. J Clin Oncol. 2021 Jun 20;39(18):2037-2048. doi: 10.1200/JCO.21.00471. Epub 2021 May 3. J Clin Oncol. 2021. PMID: 33939491
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH; American Society of Clinical Oncology. Griggs JJ, et al. Among authors: sparreboom a. J Clin Oncol. 2012 May 1;30(13):1553-61. doi: 10.1200/JCO.2011.39.9436. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473167 Review.
Drug transporters and anthracycline-induced cardiotoxicity.
Huang KM, Hu S, Sparreboom A. Huang KM, et al. Among authors: sparreboom a. Pharmacogenomics. 2018 Jul 1;19(11):883-888. doi: 10.2217/pgs-2018-0056. Epub 2018 Jul 11. Pharmacogenomics. 2018. PMID: 29991332 Review.
Pharmacogenomic importance of ABCG2.
Cusatis G, Sparreboom A. Cusatis G, et al. Among authors: sparreboom a. Pharmacogenomics. 2008 Aug;9(8):1005-9. doi: 10.2217/14622416.9.8.1005. Pharmacogenomics. 2008. PMID: 18681776 Free article. Review.
Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition.
Eisenmann ED, Fu Q, Muhowski EM, Jin Y, Uddin ME, Garrison DA, Weber RH, Woyach J, Byrd JC, Sparreboom A, Baker SD. Eisenmann ED, et al. Among authors: sparreboom a. Cancer Res Commun. 2021 Nov;1(2):79-89. doi: 10.1158/2767-9764.crc-21-0076. Epub 2021 Nov 9. Cancer Res Commun. 2021. PMID: 34950932 Free PMC article.
Polymorphic transporters and platinum pharmacodynamics.
Sprowl JA, Ness RA, Sparreboom A. Sprowl JA, et al. Among authors: sparreboom a. Drug Metab Pharmacokinet. 2013;28(1):19-27. doi: 10.2133/dmpk.dmpk-12-rv-073. Epub 2012 Sep 18. Drug Metab Pharmacokinet. 2013. PMID: 22986709 Free PMC article. Review.
Regulation of OATP1B1 Function by Tyrosine Kinase-mediated Phosphorylation.
Hayden ER, Chen M, Pasquariello KZ, Gibson AA, Petti JJ, Shen S, Qu J, Ong SS, Chen T, Jin Y, Uddin ME, Huang KM, Paz A, Sparreboom A, Hu S, Sprowl JA. Hayden ER, et al. Among authors: sparreboom a. Clin Cancer Res. 2021 Aug 1;27(15):4301-4310. doi: 10.1158/1078-0432.CCR-21-0023. Epub 2021 Mar 4. Clin Cancer Res. 2021. PMID: 33664059 Free PMC article.
244 results